Patent ID: 11918559
Assignee: PRIMUS PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 4:
5. The oral dosage form of claim 3, wherein:
a) the micronized metaxalone comprises 10% 0.8111 micronized metaxalone, 50% 10.00μ micronized metaxalone, and 90% 49.91μ micronized metaxalone, and,
b) the non-micronized metaxalone comprises 1 w/w % retained Sieve #30 non-micronized metaxalone, 49-63 w/w % retained Sieve #120 non-micronized metaxalone, and 28-30% retained Sieve #325 non-micronized metaxalone.